PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,000 | +155.6% | 9,482 | +169.5% | 0.00% | – |
| Q1 2020 | $9,000 | 0.0% | 3,518 | +17.4% | 0.00% | – |
| Q2 2019 | $9,000 | -40.0% | 2,997 | -29.0% | 0.00% | – |
| Q1 2019 | $15,000 | -68.8% | 4,221 | -79.5% | 0.00% | – |
| Q2 2018 | $48,000 | +242.9% | 20,607 | +279.9% | 0.00% | -100.0% |
| Q4 2017 | $14,000 | -84.8% | 5,424 | -80.1% | 0.00% | -75.0% |
| Q3 2017 | $92,000 | +24.3% | 27,254 | +23.1% | 0.00% | -20.0% |
| Q3 2016 | $74,000 | -18.7% | 22,131 | -24.3% | 0.01% | -16.7% |
| Q2 2016 | $91,000 | +550.0% | 29,241 | +938.4% | 0.01% | +500.0% |
| Q3 2015 | $14,000 | -89.1% | 2,816 | -84.7% | 0.00% | -93.3% |
| Q1 2015 | $129,000 | – | 18,357 | +37363.3% | 0.02% | – |
| Q4 2014 | $0 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |